Resumen
Neutral lipid storage disease with myopathy (NLSDM) is characterized by the accumulation of cytoplasmic triglyceride droplets in various tissues; this very rare condition is caused by mutations in the PNPLA2 gene, susceptible to specific pharmacological management that decreases clinical progression. We describe the clinical and biochemical characteristics of a Colombian patient with a previously unreported homozygous mutation in the PNPLA2 gene with a difficult to manage disease, who was diagnosed late by advances in molecular techniques.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 207-209 |
Número de páginas | 3 |
Publicación | Journal of Clinical Neuroscience |
Volumen | 58 |
DOI | |
Estado | Publicada - dic. 2018 |
Publicado de forma externa | Sí |